Advanced search
Publication Cover
Acta Oncologica Volume 45, 2006 - Issue 2
Journal homepage
780
Views
22
CrossRef citations to date
0
Altmetric
LETTER TO THE EDITOR

Absence of JAK2 V617F mutation in gastric cancers

Jong Woo Lee Department of Pathology, College of Medicine, The Catholic University of Korea, Seoul, Korea
,
Young Hwa Soung Department of Pathology, College of Medicine, The Catholic University of Korea, Seoul, Korea
,
Su Young Kim Department of Pathology, College of Medicine, The Catholic University of Korea, Seoul, Korea
,
Suk Woo Nam Department of Pathology, College of Medicine, The Catholic University of Korea, Seoul, Korea
,
Won Sang Park Department of Pathology, College of Medicine, The Catholic University of Korea, Seoul, Korea
,
Jung Young Lee Department of Pathology, College of Medicine, The Catholic University of Korea, Seoul, Korea
,
Nam Jin Yoo Department of Pathology, College of Medicine, The Catholic University of Korea, Seoul, Korea
&
Sug Hyung Lee Department of Pathology, College of Medicine, The Catholic University of Korea, Seoul, KoreaCorrespondence[email protected]
 show all
Pages 222-223 | Received 11 Aug 2005, Published online: 08 Jul 2009

Citations (22)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (2)

Brian L Harry, S. Gail Eckhardt & Antonio Jimeno. (2012) JAK2 inhibition for the treatment of hematologic and solid malignancies. Expert Opinion on Investigational Drugs 21:5, pages 637-655.
Read now
Ayalew Tefferi. (2008) JAK and MPL mutations in myeloid malignancies. Leukemia & Lymphoma 49:3, pages 388-397.
Read now

Articles from other publishers (20)

Wenqiang Li, Mei Li, Qian Huang, Xiaoyu He, Chen Shen, Xiaoming Hou, Fulai Xue, Zhiping Deng & Yao Luo. (2023) Advancement of regulating cellular signaling pathways in NSCLC target therapy via nanodrug. Frontiers in Chemistry 11.
Crossref
Al-Hassan M. Mustafa & Oliver H. Krämer. (2023) Pharmacological Modulation of the Crosstalk between Aberrant Janus Kinase Signaling and Epigenetic Modifiers of the Histone Deacetylase Family to Treat Cancer. Pharmacological Reviews 75:1, pages 35-61.
Crossref
Bei Huang, Xiaoling Lang & Xihong Li. (2022) The role of IL-6/JAK2/STAT3 signaling pathway in cancers. Frontiers in Oncology 12.
Crossref
Pramod D. JawalePatil, Keerti Bhamidipati, Manoj G. Damale, Jaiprakash N. Sangshetti, Nagaprasad Puvvada, Rajesh S. Bhosale, Rajita D. Ingle, Rajendra P. Pawar, Sidhanath V. Bhosale & Sheshanath V. Bhosale. (2022) Synthesis of naphthalimide derivatives bearing benzothiazole and thiazole moieties: In vitro anticancer and in silico ADMET study. Journal of Molecular Structure 1263, pages 133173.
Crossref
Ayalew Tefferi. 2020. Abeloff's Clinical Oncology. Abeloff's Clinical Oncology 1821 1835.e4 .
Tony Eight Lin, Wei-Chun HuangFu, Min-Wu Chao, Tzu-Ying Sung, Chao-Di Chang, Yi-Ying Chen, Jui-Hua Hsieh, Huang-Ju Tu, Han-Li Huang, Shiow-Lin Pan & Kai-Cheng Hsu. (2018) A Novel Selective JAK2 Inhibitor Identified Using Pharmacological Interactions. Frontiers in Pharmacology 9.
Crossref
Yutaka Shimazu. (2018) Existence of JAK2 mutation 19 years prior to the development of overt polycythemia vera . Hematological Oncology 36:1, pages 355-356.
Crossref
Yanjun Xu, Juan Jin, Jiawei Xu, Yang W Shao & Yun Fan. (2017) JAK2 variations and functions in lung adenocarcinoma. Tumor Biology 39:6, pages 101042831771114.
Crossref
Ayalew Tefferi. 2016. Holland‐Frei Cancer Medicine. Holland‐Frei Cancer Medicine 1 14 .
Zhiguo Liu, Yuguang Liu, Lianling Li, Zhenkuan Xu, Baibin Bi, Yunyan Wang & Jian Yi Li. (2014) MiR-7-5p is frequently downregulated in glioblastoma microvasculature and inhibits vascular endothelial cell proliferation by targeting RAF1. Tumor Biology 35:10, pages 10177-10184.
Crossref
Ayalew Tefferi. 2014. Abeloff's Clinical Oncology. Abeloff's Clinical Oncology 1929 1943.e4 .
Jeffrey W. Schmidt & Kay-Uwe Wagner. 2012. Jak-Stat Signaling : From Basics to Disease. Jak-Stat Signaling : From Basics to Disease 259 288 .
Cui‐Juan Qian, Jun Yao & Jian‐Min Si. (2011) Nuclear JAK2: Form and Function in Cancer. The Anatomical Record 294:9, pages 1446-1459.
Crossref
Ling Ding, Yanjun Xu, Wei Zhang, Yujie Deng, Misi Si, Ying Du, Haomi Yao, Xuyan Liu, Yuehai Ke, Jianmin Si & Tianhua Zhou. (2010) MiR-375 frequently downregulated in gastric cancer inhibits cell proliferation by targeting JAK2. Cell Research 20:7, pages 784-793.
Crossref
Ayalew Tefferi. (2009) Molecular drug targets in myeloproliferative neoplasms: mutant ABL1, JAK2, MPL, KIT, PDGFRA, PDGFRB and FGFR1. Journal of Cellular and Molecular Medicine 13:2, pages 215-237.
Crossref
Ayalew Tefferi, Ross L. Levine & Hagop Kantarjian. (2009) Oncogenic Signals as Treatment Targets in Classic Myeloproliferative Neoplasms. Biology of Blood and Marrow Transplantation 15:1, pages 114-119.
Crossref
Wojciech Gorczyca & Foxwell Nathan Emmons. 2008. Atlas of Differential Diagnosis in Neoplastic Hematopathology. Atlas of Differential Diagnosis in Neoplastic Hematopathology 542 566 .
Ayalew Tefferi. (2007) JAK2 Mutations and Clinical Practice in Myeloproliferative Neoplasms. The Cancer Journal 13:6, pages 366-371.
Crossref
Nelly Motté, Patrick Saulnier, Jean‐Pierre Le Couedic, Jean‐Charles Soria, Suzette Delaloge, Valérie Boige, Patricia Pautier, William Vainchenker, Jean‐Michel Bidart & Jean‐Luc Villeval. (2007) Mutations in JAK2 V617F homologous domain of JAK genes are uncommon in solid tumors . International Journal of Cancer 121:9, pages 2113-2115.
Crossref
Ayalew Tefferi & Animesh Pardanani. (2007) Evaluation of “Increased” Hemoglobin in the JAK2 Mutations Era: A Diagnostic Algorithm Based on Genetic Tests. Mayo Clinic Proceedings 82:5, pages 599-604.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.